Skip to main content

AstraZeneca COVID-19 Vaccine 70% Effective, UK Expects Millions Of Doses By Year's End

Continuing the pattern of leading COVID-19 vaccine projects releasing their Phase 3 trial results on Monday, AstraZeneca has revealed that its vaccine - is 70% effective at preventing the coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.